Sorriso Pharmaceuticals Launches with $31 Million to Develop Novel Class of Orally Delivered Cytokine Antibodies to Treat Inflammatory Conditions

/PRNewswire/ -- Sorriso Pharmaceuticals, a company focused on transforming anti-inflammatory antibody therapy, today announced the company has closed on a $31...

Related Keywords

Ciara Kennedy ,Arix Bioscience ,Ed Mathers ,Mark Chin ,Enterprise Associates Inc ,Sorriso Pharmaceuticals ,Enterprise Associates ,Sorriso Pharmaceuticals Inc ,New Enterprise Associates ,